Alpha Teknova, Inc.
General ticker "TKNO" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $217.4M (TTM average)
Alpha Teknova, Inc. follows the US Stock Market performance with the rate: 49.6%.
Estimated limits based on current volatility of 4.1%: low 7.39$, high 8.01$
Factors to consider:
- Total employees count: 158 (-8.7%) as of 2025
- US accounted for 94.4% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Operating losses, Regulatory and compliance, Construction delays, Product defects, Cybersecurity threats
- Current price 37.8% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.06$, 5.14$]
- 2026-12-31 to 2027-12-31 estimated range: [1.69$, 4.27$]
Financial Metrics affecting the TKNO estimates:
- Positive: with PPE of -12.2 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: 58.56 < Shareholder equity ratio, % of 66.40 <= 69.38
- Positive: Industry inventory ratio change (median), % of -0.31 <= 0
- Positive: Inventory ratio change, % of -0.38 <= -0.37
- Positive: -51.61 < Industry operating profit margin (median), % of -17.91
Short-term TKNO quotes
Long-term TKNO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $36.68MM | $37.74MM | $40.52MM |
| Operating Expenses | $72.25MM | $63.89MM | $57.50MM |
| Operating Income | $-35.56MM | $-26.15MM | $-16.98MM |
| Non-Operating Income | $-1.51MM | $-0.69MM | $-0.23MM |
| Interest Expense | $0.83MM | $0.69MM | $0.23MM |
| R&D Expense | $5.57MM | $2.76MM | $2.20MM |
| Income(Loss) | $-37.08MM | $-26.83MM | $-17.20MM |
| Taxes | $-0.30MM | $-0.09MM | $0.06MM |
| Net Income(Loss)* | $-36.78MM | $-26.75MM | $-17.26MM |
| Stockholders Equity | $90.04MM | $82.39MM | $68.78MM |
| Inventory | $11.59MM | $6.80MM | $7.05MM |
| Assets | $128.59MM | $118.77MM | $103.58MM |
| Operating Cash Flow | $-18.81MM | $-12.39MM | $-8.65MM |
| Capital expenditure | $7.93MM | $1.12MM | $1.15MM |
| Investing Cash Flow | $-7.74MM | $-27.27MM | $10.70MM |
| Financing Cash Flow | $12.80MM | $14.89MM | $0.15MM |
| Earnings Per Share** | $-1.16 | $-0.57 | $-0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.